News & Events

View recent news and events relating to research at Providence Health Care.

Subscribe to our weekly newsletters here to keep updated with the latest news and events from Providence Research.

2022 Research and Mission Award Winner, Dr. Zabrina Brumme

Vancouver, BC – Dr. Darryl Knight, President, Providence Research, Vice President, Research & Academic Affairs, Providence Health Care (PHC) and Associate Dean - Research, Faculty of Medicine, University of British Columbia (UBC) is pleased to announce the winner of this year’s Research and Mission Award, Dr. Zabrina Brumme.

Providence Research is pleased to announce the appointment of Graeme Koelwyn Tier 2 Canada Research Chair in Public Health at Simon Fraser University

Providence Research is pleased to announce the appointment of assistant professor Graeme Koelwyn as its Tier 2 Canada Research Chair (CRC) in Public Health ‘Omics in Exercise and Disease. This chair is the fourth CRC held at Simon Fraser University (SFU) Faculty of Health Sciences (FHS).                                                              


Treating wounds is a complex and challenging healthcare puzzle. From people in long-term and acute care situations, to those living with hard to heal wounds, it is a troubling and severe health condition.

If you are interested in submitting a problem about wounds or participating as an innovator, you need to attend the next Providence Research, Skunkworks: Hacking Wounds event.  


Curated Care: Unlocking the secrets of precision medicine | May 12th, 2022

On May 12, 2022, Providence Research along with the St. Paul's Foundation presented Curated Care: Unlocking the secrets of precision medicine. The guest speakers, Dr. Darryl Knight, President, Providence Research, Brianna Davies, Genetic Counsellor, Inherited Heart Rhythm Research, St. Paul's Hospital and  Dr. Brian Westerberg, Head, Division of Otolaryngology, Head and Neck Surgery, Providence Health Care, discussed harnessing technology, data and our own DNA to transform patient care.

Appointment of PHC Chief Operating Officer

Dear Providence Family:

On behalf of the Senior Leadership Team, it’s my great pleasure to announce the appointment of Norm Peters as Chief Operating Officer (COO) for Providence Health Care, effective June 20th.

Norm joins us from his previous Senior Executive Team role at Fraser Health as Vice President, Regional Care Integration.

Clinical Trials at the Speed of COVID-19: Flexibility and Rapid Innovation



The Centre for Health Evaluation and Outcome Sciences (CHÉOS) in partnership with the UBC School of Population and Public Health (SPPH), presents the first in a symposium series dedicated to discussing clinical trials that are timely, responsive and adaptive to emergent health emergencies.

Dr. Mari DeMarco Winner of the 2022 Michael S. Bereman Award for Innovative Clinical Proteomics

This year's Michael S. Bereman Award for Innovative Clinical Proteomics, sponsored by Agilent, was won by Dr. Mari DeMarco, a Clinical Chemist, at St. Paul's Hospital, Providence Health Care, Research Director, Providence Research, Clinical Associate Professor, Department of Pathology & Laboratory Medicine, University of British Columbia, Investigator, and Center for Heart & Lung Innovation, University of British Columbia. The award was presented to Dr.

Overdose Prevention Sites give Health, Social Benefits: Research

The expansion of overdose prevention sites (OPS) in Vancouver in recent years is linked to a range of health benefits, including more connection to addiction treatment and decreased public injection and syringe sharing, new research says.

World AIDS Day: BC's Success Story Shows Strength of Treatment as Prevention

On December 1st we celebrate World AIDS Day, an opportunity to reflect on our challenges and successes four decades into the battle against HIV/AIDS.

Around the world there are nearly 38 million people living with HIV and about 1.5 million new infections per year. A recent report by the World Health Organization estimates the number of people with the virus being treated with antiretrovirals had risen to 27.5 million – an increase of almost 10 per cent over the last year. Encouraging but not enough